Abstract:What's new? Many cancer patients are at increased risk of mental health issues. This risk likely was heightened during the COVID‐19 pandemic, though understanding of the pandemic's impact on mental health in cancer remains uncertain. Here, clinical and sociodemographic risk factors for anxiety and depression were analyzed for cancer patients and survivors during the COVID‐19 pandemic. Female sex, lung cancer, active disease, and low income or restricted contact with relatives or physicians were key risk factors for anxiety and depression. In particular, the findings highlight the importance of social contact as a modifiable risk factor for the mental health of cancer patients. Treatment modifications and contact restrictions were common during the COVID‐19 pandemic and can be stressors for mental health. There is a lack of studies assessing pandemic‐related risk factors for anxiety and depression of cancer patients and survivors systematically in multifactorial models. A total of 2391 participants, mean age 65.5 years, ≤5 years post‐diagnosis of either lung, prostate, breast, colorectal cancer, or leukemia/lymphoma, were recruited in 2021 via the Baden‐Württemberg Cancer Registry, Germany. Sociodemographic information, pandemic‐related treatment modifications, contact restrictions, and anxiety/depression (Hospital Anxiety and Depression Scale, HADS) were assessed via self‐administered questionnaire. Clinical information (diagnosis, stage, and treatment information) was obtained from the cancer registry. Overall, 22% of participants reported oncological care modifications due to COVID‐19, mostly in follow‐up care and rehabilitation. Modifications of active cancer treatment were reported by 5.8%. Among those, 50.5% had subclinical anxiety and 55.4% subclinical depression (vs. 37.4% and 45.4%, respectively, for unchanged active treatment). Age <60 years, female sex, lung cancer, low income, and contact restrictions to peer support groups or physicians were identified as independent risk factors for anxiety. Risk factors for depression were lung cancer (both sexes), leukemia/lymphoma (females), recurrence or palliative treatment, living alone, low income, and contact restrictions to relatives, physicians, or caregivers. The study demonstrates that changes in active cancer treatment and contact restrictions are associated with impaired mental well‐being. The psychological consequences of treatment changes and the importance for cancer patients to maintain regular contact with their physicians should be considered in future responses to threats to public health.

Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis

Posttraumatic stress, depression and anxiety among adult long-term survivors of cancer in adolescence

A systematic review on the prevalence of symptoms of depression, anxiety and distress in long‐term cancer survivors: Implications for primary care

Comorbid conditions and health-related quality of life in long-term cancer survivors-associations with demographic and medical characteristics

Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis

Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors

Early, medium and long-term mental health in cancer survivors compared with cancer-free comparators: matched cohort study using linked UK electronic health records

Depression and cancer survivorship: importance of coping self-efficacy in post-treatment survivors.

Anxiety, depression, and concentration in cancer survivors: National Health and Nutrition Examination Survey results

Anxiety and depression after diagnosis of high-risk primary cutaneous melanoma: a 4-year longitudinal study

Are cancer patients with high depressive symptom levels able to manage these symptoms without professional care? The role of coping and social support

Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study

Late effects, long‐term problems and unmet needs of cancer survivors

Trends in the prevalence and treatment of comorbid depression among US adults with and without cancer, 2005–2020

First Anxiety, Afterwards Depression: Psychological Distress in Cancer Patients at Diagnosis and after Medical Treatment

Factors Associated with Depression Assessed by the Patient Health Questionnaire-2 in Long-Term Cancer Survivors

Anxiety and depression in cancer patients and survivors in the context of restrictions in contact and oncological care during the COVID‐19 pandemic

Prevalence of major depression, suicidal ideation, and mental health treatment among cancer survivors

Healthcare use and costs in adult cancer patients with anxiety and depression

Screening for post‐traumatic stress disorders in 1017 cancer patients and correlation with anxiety, depression, and distress

Mental Health Challenges in Cancer Patients: A Cross-Sectional Analysis of Depression and Anxiety